Eugene L. Piatnitski Chekler
Ono Pharmaceutical (United States)(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Computational Drug Discovery Methods, Protein Structure and Dynamics, Angiogenesis and VEGF in Cancer, Multiple Myeloma Research and Treatments
Most-Cited Works
- → Target validation using chemical probes(2013)434 cited
- → Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects(2020)296 cited
- → Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities(2015)60 cited
- → Kiloscale Buchwald–Hartwig Amination: Optimized Coupling of Base-Sensitive 6-Bromoisoquinoline-1-carbonitrile with (S)-3-Amino-2-methylpropan-1-ol(2014)45 cited
- → Structure-Based Design of Highly Selective Inhibitors of the CREB Binding Protein Bromodomain(2017)40 cited
- → Arylphthalazines as potent, and orally bioavailable inhibitors of VEGFR-2(2008)37 cited
- → Efficient one-pot synthesis of substituted 2-amino-1,3,4-oxadiazoles(2008)37 cited
- → Antitumor Activity of IMC-038525, a Novel Oral Tubulin(2010)29 cited
- → Discovery of Dual VEGFR-2 and Tubulin Inhibitors with in Vivo Efficacy(2010)27 cited